Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 2327 results found since Jan 2013.
Smartphone-based active vaccine safety surveillance (SmartVax) at a Swiss adult vaccination clinic - a pilot study
CONCLUSION: Monitoring post-licensure vaccine safety using the active SMS-based surveillance system SmartVax is feasible in Switzerland. We observed a high acceptance in the diverse study population, including healthcare workers and IMID patients. High response rates in the elderly and reliable monitoring almost in real-time make SmartVax a promising tool for COVID-19 vaccine safety monitoring.PMID:34908642 | DOI:10.4414/smw.2021.w30090
Source: Swiss Medical Weekly - December 15, 2021 Category: General Medicine Authors: Daniela S Guedel Ian J Peters Florian Banderet Varenka Epple Sabine Egli Matthias Mehling Michael Mayr Alan Leeb Christoph T Berger Source Type: research
Complications and cost estimations in herpes zoster - a retrospective analysis at a Swiss tertiary dermatology clinic
CONCLUSION: In this herpes zoster population at a university hospital, one in three patients was affected by herpes zoster-related complications. Age and cancer were independently associated with a high complication rate, suggesting a need to vaccinate cancer patients. Herpes zoster-related complications and the need for inpatient treatment escalated the costs per case.PMID:34964592 | DOI:10.4414/smw.2021.w30081
Source: Swiss Medical Weekly - December 29, 2021 Category: General Medicine Authors: Leonard D Bongers Alexander Navarini Christoph T Berger Simon M Mueller Source Type: research
Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012.
PMID: 25345520 [PubMed - in process]
Source: Euro Surveill - October 31, 2014 Category: Infectious Diseases Authors: Kelly H, Grant K, Gidding H, Carville K Tags: Euro Surveill Source Type: research
Herpes Vaccine Safe in Patients With Arthritis on BiologicsHerpes Vaccine Safe in Patients With Arthritis on Biologics
Patients with autoimmune and inflammatory diseases are more prone to getting herpes zoster than the general population, but these patients can be safely vaccinated, a new study has suggested. Medscape Medical News
Source: Medscape Medical News Headlines - November 28, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Vaccine Uptake Among Adults Better, but Still LowVaccine Uptake Among Adults Better, but Still Low
In 2013, adult uptake for herpes zoster, Tdap, and HPV vaccines increased slightly, but others did not, according to a CDC report. Medscape Medical News
Source: Medscape Medical News Headlines - February 6, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Newer Herpes Zoster Vaccine Effective Even in Older AdultsNewer Herpes Zoster Vaccine Effective Even in Older Adults
A recombinant subunit vaccine significantly lowered the risk for herpes zoster in adults aged 50 years or older, with comparable efficacy in adults aged 70 years or older. Medscape Medical News
Source: Medscape Medical News Headlines - April 30, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Shingles Vaccination Helps Some Who Later Develop the Virus Shingles Vaccination Helps Some Who Later Develop the Virus
Adults who developed herpes zoster despite having received the herpes zoster vaccine had a reduced risk for painful complications compared with their unvaccinated counterparts. Medscape Medical News
Source: Medscape Medical News Headlines - June 15, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Routine Shingles Vaccination in 50-Year-Olds Does Not Pay Routine Shingles Vaccination in 50-Year-Olds Does Not Pay
A new study supported the Advisory Committee on Immunization Practices recommendation that routine immunization against herpes zoster in immunocompetent adults should begin at age 60 years. Medscape Medical News
Source: Medscape Medical News Headlines - September 9, 2015 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Outbreak of chickenpox in a Union Territory of North India
Conclusion: The introduction of varicella vaccine in the universal immunisation programme of India may help to prevent these outbreaks; however, the cost-benefit analysis needs to be carried out before making such policies.
Source: Indian Journal of Medical Microbiology - October 16, 2015 Category: Microbiology Authors: MP SinghC ChandranA SarwaA KumarM GuptaA RajRK Ratho Source Type: research
Medical News Today: Asthma linked to increased risk of shingles
A new study finds that asthma is a risk factor for herpes zoster or shingles in adults and suggests considering the over-50s with asthma as a target group for zoster vaccination.
Source: Health News from Medical News Today - December 29, 2015 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news
